At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. He's written a memoir ...

Multiple myeloma is a rare type of blood cancer that occurs when white ... The disease can lead to bone damage or loss, resulting in pain for the patient. The spine, pelvis, and rib cage are the most ...

I reflect on finding peace, purpose and presence after my diagnosis through a creative writing exercise rooted in mindfulness ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

JNJ-79635322 shows favorable responses and manageable safety in BCMA/GPRC5D-naïve patients with relapsed/refractory multiple ...

A high-fiber, plant-based dietary intervention and nutritional counseling improved several risk factors for multiple myeloma, ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

Despite the potential utility, this approach has not been widely adopted in clinical practice as, although investigators have found powerful prognostic GS’s in myeloma, it is unclear how to make ...

MBD was detected using axial survey in My9 and My11, axial skeletal survey (2001–2010) and whole body computed tomography (2011 onwards) in HdB and combined skeletal survey and skeletal computed ...

GSK's BCMA-directed antibody-drug conjugate Blenrep reduced the risk of death by 42% in a multiple myeloma trial that the company believes could be practice-changing. The DREAMM-7 study showed ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical ...